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Abstract 
 
The rate of repolarization (RRepol) and so the duration of the cardiac action potential is 
determined by the balance of inward and outward currents across the cardiac membrane (net 
ionic current). Plotting action potential duration (APD) as a function of the RRepol reveals an 
inverse non-linear relationship, arising from the geometric association between these two 
factors. From the RRepol-APD relationship it can be observed that a longer action potential will 
exhibit a greater propensity to shorten, or prolong, for a given change in the RRepol (i.e. net ionic 
current), when compared to one that is initially shorter. This observation has recently been used 
to explain why so many interventions that prolong the action potential exert a greater effect at 
slow rates (reverse rate-dependence). In this article we will discuss the broader implications of 
this simple principle and examine how common experimental observations on the electrical 
behavior of the myocardium may be explained in terms of the RRepol-APD relationship. An 
argument is made, with supporting published evidence, that the non-linear relationship between 
the RRepol and APD is a fundamental, and largely overlooked, property of the myocardium. The 
RRepol-APD relationship appears to explain why interventions and disease with seemingly 
disparate mechanisms of action have similar electrophysiological consequences. Furthermore, 
the RRepol-APD relationship predicts that prolongation of the action potential, by slowing 
repolarization, will promote conditions of dynamic electrical instability, exacerbating several 
electrophysiological phenomena associated with arrhythmogenesis, namely, the rate-
dependence of dispersion of repolarization, APD restitution and electrical alternans.  
 
Keywords: action potential duration; reverse rate-dependence; dispersion of repolarization; 
restitution; alternans; repolarization dynamics. 
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Article 
 
In 2006 Zaza and Varró published a novel hypothesis on the mechanisms by which class III 
anti-arrhythmic drugs act to act to prolong the duration of the cardiac action potential to a 
greater extent at slow rates (so called reverse rate-dependence (RRD)).1 Their principle 
observation, which is discussed in more detail later in this article, was that RRD is an intrinsic 
property of the myocardium; a consequence of the non-linear relationship between action 
potential duration (APD) and the rate of repolarization (RRepol) (or net ionic current across the 
cardiac membrane, see Figure 1). This idea, which follows from observations on the importance 
of membrane potential velocity in governing intrinsic heart rate variability,2, 3 has recently been 
validated in experimental studies.4, 5 The purpose of the present article is to highlight the 
broader importance of this simple principle. In this article we will examine how common 
experimental observations, on the electrical properties of the myocardium, may be understood 
in terms of the non-linear RRepol-APD relationship. This simple principle appears to explain why 
many factors that modify APD, but by disparate modes of action, have similar 
electrophysiological consequences. We will argue, using existing published data, that the non-
linear relationship between RRepol and APD is a fundamental, and largely overlooked, property of 
the myocardium. The RRepol-APD relationship predicts that prolongation of the action potential, 
by slowing repolarization, will promote conditions of dynamic electrical instability, exacerbating 
several rate-dependent phenomena associated with arrhythmogenesis (i.e. steeper dependence 
of regional repolarization gradients on heart rate, augmented APD restitution (APD-RT) kinetics 
and the amplification of electrical alternans). These ideas and their potential clinical implications 
will be discussed. 
 
The rate of repolarization-action potential duration relationship 
In order to understand the observations of Zaza and Varró,1 and experimental validation of 
Nánási and colleagues,4, 5 we must first consider the following equation, which tells us that the 
total membrane current (ITotal) can be calculated from the product of the capacitive and ionic 
currents. 
 
 
 
𝐼𝑇𝑜𝑡𝑎𝑙 =  𝐶𝑚  
𝑑𝑉
𝑑𝑡
+  𝐼𝐼𝑜𝑛𝑖𝑐 
(Equation 1) 4, 6 
 
where Cm represents the membrane capacitance, dV/dt the change in transmembrane voltage 
over time and IIonic the total ionic current. If all transmembrane elements are subject to the same 
membrane potential then total membrane current (ionic + capacitive) must necessarily equal 
zero (see Zaza7). Therefore, we can simplify to Equation 2.  
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𝐼𝐼𝑜𝑛𝑖𝑐 =  − 𝐶𝑚
𝑑𝑉
𝑑𝑡
 
(Equation 2) 4, 6 
 
This says that the ionic current is equal to the product of membrane capacitance and the rate of 
change of transmembrane potential (with an opposite sign). Thus, we can estimate net ionic 
current from the first derivative of the membrane potential waveform. This is the methodology 
used by Bányász et al. and Bárándi et al. who plotted APD as a function of the net ionic current 
at 50% repolarization to generate Figures 1A & 1B, respectively.4, 5 We can also observe that, 
as the membrane capacitance is fixed, any change in net ionic current (i.e. the balance of 
inward and outward currents) will generate a proportional change in the RRepol. In this regard, if 
we assume that the RRepol is constant, Figure 1 can be seen to arise as a result of the 
geometrical relationship between the slope of repolarization and the duration of the action 
potential (see Figure 2). Moreover, as the same relationship can be derived from experimental 
action potential recordings, when APD is plotted a function of the average RRepol during 
repolarization (see Figure 1C&D), this is not simply an artifact of selecting a single arbitrary 
point during repolarization. Complications arising from a notch and dome shaped action 
potential to the relationship between APD and RRepol have been discussed previously.4 
The upshot of all this is that a longer action potential will exhibit a greater propensity to shorten, 
or prolong, for the same magnitude change in the RRepol (i.e. change in IIonic), simply because the 
initial RRepol is already less steep. This is the principle reason why class III anti-arrhythmic drugs 
act in a reverse rate-dependent manner (see below). Note that alterations in the RRepol during 
the plateau, when dV/dt is small, will have the greater impact on APD than those that occur later 
in repolarization. There is also some evidence that the magnitude of the inwardly rectifying (IK1) 
and rapid delayed rectifying (IKr) potassium currents are related to the shape of the action 
potential, being potentiated at faster RRepol.8, 9 Such “self-augmentation” would increase the 
magnitude of change in APD, whereby an slowing of the RRepol during the plateau would also 
slow terminal repolarization, however, not all studies support this hypothesis10. 
In the remainder of this article we will discuss the findings, and implications, of recent studies on 
the RRD of class III anti-arrhythmic drugs and the role of the RRepol-APD relationship as an 
underpinning for common experimental observations in cardiac electrophysiology. Discussion 
will primarily focus on alterations in rate-dependent phenomena at the level of the ventricles in 
larger mammalian species (i.e. guinea pig, rabbit, dog and man).  
 
Reverse rate-dependence of anti-arrhythmic drugs 
The maintenance of re-entrant arrhythmia depends upon conduction velocity and refractory 
period, the so-called cardiac wavelength (i.e. the product of conduction velocity and the 
functional refractory period). Factors that decrease conduction velocity, or shortening refractory 
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period, may facilitate arrhythmia because they will reduce the minimum volume of tissue 
required for functional re-entry.11 Class III anti-arrhythmic agents block outward potassium 
current to prolong repolarization, and the refractory period, and so may prevent re-entry by 
increasing the cardiac wavelength. An ideal class III agent is one that exhibits a positive rate-
dependence, prolonging APD to a greater degree at fast rates, such as during ventricular 
tachyarrhythmia. However, the development of class III anti-arrhythmic drugs with positive rate 
dependence has proved elusive.4, 12 Drugs that reduce outward potassium current are 
commonly reported to prolong repolarization to a greater degree at slow heart rates. 4, 12 As 
such, class III anti-arrhythmic drugs would be predicted to be less effective during 
tachyarrhythmia. Furthermore, augmented action potential prolongation with bradycardia may 
trigger early afterdepolarisations and torsade de pointes (TdP), a polymorphic ventricular 
tachycardia associated with syncope and sudden death. The failure of pure class III anti-
arrhythmic agents to prevent death from ventricular arrhythmia in clinical trials13, 14 and 
conflicting results of experimental studies (see Table 6 in Tsuchihashi & Curtis15) may be 
explained by this lack of efficacy at faster rates and the adverse consequences of RRD.  
Although several mechanisms have been proposed to underpin the RRD of class III anti-
arrhythmic agents, including the mode of drug-channel interactions,16 ion channel kinetic 
properties,17 and potassium accumulation in the  sarcolemmal cleft,18 recent evidence has 
highlighted the non-linear relationship between net ionic current (i.e. the RRepol) and APD as an 
important contributory mechanism. Bányász et al. investigated the effect of pharmacological 
interventions, and the direct injection of current, on the rate-dependence of APD in isolated 
canine ventricular myocytes.4 Data from this study are reproduced in Figure 3, the principle 
finding of which is that there exists a commonality between interventions that modulate APD 
and their impact on APD rate-dependence. Despite different mechanisms of action, 
pharmacological interventions that prolong APD were found act in a RRD manner. This includes 
BaCl2 (an inhibitor of IK1), dofetilide (an inhibitor of IKr), Bay K8644 (an agonist of the L-type 
inward calcium current, ICal), and veratradine (an agonist of the inward sodium current, INa) 
Similarly, interventions that shorten APD (namely, nicrorandil and lidocaine) were found to have 
a greater effect at slow rates (see Figure 3A). Importantly, Bányász et al. went on to 
demonstrate that pharmacological RRD could be mimicked by the injection of outward and 
inward currents during the action potential (Figure 3B). This indicates that RRD is unlikely to be 
due to specific ion channel kinetics or mechanisms of drug action, but arises primarily as an 
intrinsic property of the cardiac membrane. In support of this, injection of inward current was 
shown to abolish the RRD prolongation of APD with BaCl2 inhibition of IK1 (Figure 3C). The 
authors concluded that the non-linear relationship between IIonic and APD is an important 
principle underpinning RRD, though they note that this does not exclude a role for other 
mechanisms (e.g. the nature of drug-channel interactions). Importantly, in a follow-up study, it 
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was shown that the magnitude of change in APD with various pharmacological interventions is 
not a direct function of heart rate but is actually determined by the initial APD.5 Slowing heart 
rate prolongs APD and so the magnitude of response (to a drug) is observed to be greater at 
slow rates. From our earlier discussion we can see why this is the case. Assuming that a given 
intervention has the same net effect at all heart rates we can observe that a longer action 
potential will exhibit a greater propensity to shorten, or prolong, for the same change in RRepol 
(i.e. IIonic), in comparison to an action potential of shorter initial duration. This is the geometric 
relationship illustrated in Figure 2. The implication here is that developing selective class III anti-
arrhythmic agents with an absence of RRD is unlikely to be successful.  
 
Rate dependency of dispersion of repolarization 
It is well established that ventricular APD, and repolarization times, are spatially and temporally 
inhomogeneous19-21 and there is convincing experimental evidence to indicate that dispersion of 
repolarization is influenced by heart rate. The vast proportion of experimental data, primarily 
from studies in the dog, indicates that slowing of rate, by pacing or autonomic nerve stimulation, 
acts to magnify regional differences in APD.22-34 This observation may be best explained by the 
RRepol-APD relationship. 
In the preceding section we discussed how the initial duration of the action potential (i.e. RRepol) 
determines the magnitude of prolongation when heart rate is slowed (in isolated ventricular 
myocytes). The corollary of this is that in the intact heart bradycardia would be expected to 
magnify regional differences in APD. If we assume that a slowing of rate results in a uniform 
decrease in the RRepol throughout the ventricles then a greater prolongation of APD would be 
expected to occur in regions where APD is relatively prolonged, in comparison to those that 
APD is relatively short, due to the non-linear RRepol-APD relationship. This can be fully 
appreciated from Figure 4A, which illustrates the predicted effect of slowing heart rate (modeled 
as a uniform slowing in the RRepol) on the APD dispersion. The initial difference in APD between 
two regions (R1 and R2) increases when heart rate is slowed. Furthermore, the magnitude of 
change in dispersion with bradycardia will directly depend upon degree of APD heterogeneity at 
baseline. Any factor (drug or disease) that increases the heterogeneity of APD, in the absence 
of some opposing effect, would be predicted to exacerbate the increase in APD dispersion on 
the slowing of heart rate. This can be readily appreciated from Figure 4B and existing 
experimental evidence supports this hypothesis. For example, we recently showed that 
bradycardia, induced by electrical stimulation of the vagus nerve, increases apicobasal 
dispersion of repolarization in the left ventricle of isolated perfused rabbit hearts (see Figure 
4C).35 Treatment with E4031, a selective blocker of IKr conductance, prolongs APD, increases 
region-to-region differences baseline APD and augments the rate-dependent increase in 
dispersion associated with vagus nerve stimulation. This is illustrated by the linear correlation 
between the initial APD and the magnitude of APD prolongation (Figure 4D), where bradycardia 
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acts to prolong the action potential to a greater extent in regions with longer baseline APD. A 
similar dependence on initial conditions has been reported in dogs with pharmacologically 
induced long QT type 3 (INa dependent), whereby increased APD heterogeneity at baseline is 
associated with a potentiation of the increase in dispersion observed when heart rate is slowed. 
23, 33 Augmented rate-dependence of dispersion of repolarization has also been reported in mice 
with congenital long QT type 3.31 As such, the relationship between greater regional APD 
heterogeneity, and its augmentation at slow rates, does not appear to be specifically related to 
one class of ion channels, or drugs, and may be generally understood in terms of the APD-RRepol 
relationship. 
From a clinical perspective bradycardia is known to be predisposing factor for the occurrence of 
the TdP in pharmacologically acquired long QT syndrome36 and death commonly occurs at night 
in congenital long QT type 3, when vagal tone is high and heart rate relatively slowed.37 
Experimental models of acquired (pharmacological inhibition of IKr) and congenital type 3 long 
QT syndrome indicate that these conditions are associated with increased spatiotemporal 
dispersion of repolarization and that this is exacerbated at the slow rates required to trigger 
TdP.28, 29, 31, 32 Non-uniformities of APD, secondary to bradycardia, can provide a substrate for 
functional conduction block and re-entrant excitation, with early afterdepolarisations acting as a 
focal trigger.33 Both focal and re-entrant mechanisms are thought to contribute to the initiation 
and maintenance TdP in long QT syndrome.33, 38 
   
Action potential duration restitution  
In most larger mammalian species (i.e. human, dog, guinea-pig) a decrease in the inter-beat 
coupling interval or, more correctly, diastolic interval (DI) results in a shortening of the 
ventricular action potential. The APD-RT curve, as illustrated in Figure 5, plots APD as a 
function of a decreasing DI and approximates a mono-exponential curve (the bi-phasic rabbit 
APD-RT curve, demonstrating APD prolongation (with decreasing DI) at long cycle lengths, is a 
notable exception – although the rabbit is largely mono-phasic over physiological heart rates39). 
APD-RT involves a number of ionic processes, including, a reduction of intracellular calcium 
transient amplitude leading to a decrease of inward current through the sodium-calcium 
exchanger,40 incomplete reactivation and a decrease of the inward calcium current,40, 41 
incomplete deactivation and an increase of outward K+ currents40, 42 and self-augmentation of 
outward K+ currents.8 The net effect is that as DI is decreased there is a reduction of inward and 
increase in outward current, resulting in a shorter action potential. This capacity of the action 
potential to adjust to a sudden perturbation in rate clearly plays a important physiological role; 
accommodating fast heart rates, reducing the risk of conduction block when rate suddenly 
increases (fight or flight) and, conversely, preventing early re-excitation when rate is slowed. 
However, the APD-RT curve is also implicated in ventricular arrhythmogenesis. The slope of the 
restitution curve has been proposed as a mechanism whereby organized ventricular tachycardia 
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can transition to “chaotic” ventricular fibrillation.43 APD-RT is also implicated in the mechanisms 
mediating re-entrant arrhythmia, whereby regional restitution properties act, in concert with the 
timing of a premature stimulus, to determine the occurrence functional re-entry44 This is similar 
to computational simulations suggesting that spatial heterogeneity of APD-RT is a pro-
arrhythmogenic substrate.45  
As the APD-RT curve depends upon a number of cellular processes it is reasonable to assume 
that factors that alter the duration of the action potential will have different effects depending 
upon their specific mechanism of action. However, a review of the literature reveals a startlingly 
consistent relationship between modulation of APD and its impact on the APD-RT curve. 
Factors that act to prolong APD are commonly reported to increase the kinetics of the APD-RT 
relationship, demonstrating a greater shortening of APD over the same range of DIs, and an 
increase in APD-RT slope. These factors include bradycardia,46 experimental heart failure,47 
excitation-contraction uncoupling agents48, 49 and the action of drugs that prolong APD by 
reducing outward K+ current50-52 or increasing inward Na+ current.53 By comparison, factors that 
shorten APD act to flatten the APD-RT curve (see Figure 5).50, 54-56 It is, however, not 
immediately apparent why interventions with seemingly disparate mechanisms of action have 
similar electrophysiological consequences. This observation cannot simply be ascribed to 
changes in intracellular ion accumulation, as this differs in each case. For instance, whilst 
bradycardia causes a reduction in both intracellular sodium ([Na+]i) and calcium ([Ca2+]i), 
potassium channel block will increase [Ca2+]I without effect on [Na+]i and sodium channel 
activation will elevate both [Na+]i and [Ca2+]I. Despite this, all 3 interventions have been shown 
to increase the magnitude of APD-RT.46, 50-53 Additionally, it is difficult to understand why 
interventions that would be predicted to flatten the APD-RT curve (e.g. a decrease in K+ 
conductance) actually have the opposite effect.50-52 We propose that this disparity may be 
understood by considering the non-linear relationship between RRepol and APD. 
Figure 5A illustrates two theoretical APD-RT curves generated using the RRepol-APD 
relationship. Starting from a predefined APD (circles=normal, squares=prolonged) the process 
of electrical restitution is modeled as a series of incremental step increases in the RRepol,, with 
estimated APD plotted, at each step, against a predefined range of DIs. Note that the range of 
DIs here is essentially arbitrary and is the same in both curve. As such, Figure 5A models the 
increase in net outward current with decreasing DI and allows us to predict the effect of altering 
the initial duration of the action potential on the APD-RT curve. From Figure 5A we can see that 
restitution of APD is predicted to be of greater magnitude, and the slope of the APD-RT curve 
steeper, when initial APD is longer. By definition this will arise independently of other factors 
that may influence restitution (e.g. changes in intracellular calcium load or sodium channel 
gating). Moreover, in accordance with studies on AP adaptation,4, 5 this is expected to be 
somewhat independent of the mechanism by which APD is prolonged (i.e. specific ionic 
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conductance(s)). To reiterate this point, the implication from the RRepol-APD relationship is that 
magnitude of APD-RT is, in part, a function of the initial APD and that this explains the 
commonality that factors that prolong APD also increase the kinetics of the APD-RT curve. Note 
that, in Figure 3A, due to the exponential nature of the RRepol-APD relationship, the two APD-RT 
curves converge at the same point. This observation of converging curves is seemingly a 
universal feature of experimental studies in which APD-RT is compared before and after an 
intervention that modifies APD (with recordings made either in the same cell / region of the heart 
or in matched samples) and several examples of this pattern are presented in Figure 5. The fact 
that this is so consistently observed suggests a common mechanism and this is likely to be the 
RRepol-APD relationship. 
It is clear from Figure 5 that, while APD prolongation generally increases the kinetics of 
restitution process, there are some notable differences in the profile of the APD-RT curve 
between interventions. This serves to highlight the fact that whilst the RRepol-APD relationship 
may play an important role it is not the only factor that will influence APD-RT. If, for example, a 
particular ion channel, or pump, contributes to the shortening of APD at very short DIs (e.g. ICal) 
then this would clearly impact on the shape of the terminal portion of the APD-RT curve. 
Similarly, if an intervention modifies intracellular calcium handling this may alter the calcium 
dependent portions of the curve, reducing or augmenting the change in ionic current over a 
given range of DIs.  
 
Electrical alternans 
Electromechnical cardiac alternans refers to the cyclic variation in the duration of ventricular 
APD (long-short-long-short) and intracellular calcium transient (large-small-large-small) 
observed at rapid heart rates.57 Clinically this takes the form of macro or microscopic oscillations 
in the amplitude and/or duration of the electrocardiographic T-wave. Alternans are commonly 
observed in conditions associated with increased risk of arrhythmia56, 58-62 and clinical trials have 
established that microvolt T-wave alternans are a predictor of risk of tachyarrhythmia and 
sudden cardiac death.63, 64 It is beyond the scope of this article to discuss the multitude of 
cellular and multicellular properties that contribute to the phenomenon of cardiac alternans and 
readers requiring additional information are directed to Weiss et al.57 We will instead focus on 
the impact of a change in APD on cardiac alternans and the proposed of the importance of the 
RRepol-APD relationship.  
Existing experimental evidence indicates that the magnitude of electrical alternans is increased 
by interventions that prolong49, 65-67, and decreased by those that shorten,49, 67-69 the action 
potential. Figure 6A, with data from Fossa et al.,60 demonstrates the occurrence of significant 
APD alternans with rapid pacing in guinea pig hearts, in the presence of E4031 but not in 
control conditions. As with APD-RT, the potentiation of alternans appears to be a function of the 
duration of the action potential rather than a property related to any individual ion channel. In 
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support of this we can observe that alternans are potentiated by interventions that prolong APD 
by increasing inward Na+ current 70, 71 or decreasing outward K+ currents.65 Moreover, data from 
Fujimoto et al. demonstrates that the increase in alternan amplitude with disopyramide mediated 
APD prolongation can be reversed by nicorandil, an activator of the ATP sensitive potassium 
current.67 
Altering the duration of the action potential will influence cardiac alternans through several 
interrelated mechanisms. The first is that when the action potential is prolonged there will be an 
increase Ca2+ entry through ICal, which will enhance [Ca2+]I and amplify beat-to-beat oscillations 
in calcium transient amplitude (and so APD). Secondly, the RRepol-APD relationship predicts that 
prolonging repolarization will magnify the beat-to-beat oscillation in APD associated with cycling 
of intracellular calcium (Figure 6A). The amplitude of the calcium transient directly modulates 
the action potential by potentiating inward current through the sodium-calcium exchanger (NCX) 
and / or reducing inward current through ICal but may also activate calcium-dependent chloride 
currents, 72 IK1,73 Ito74 and the delayed rectifying K+ currents.75 The relative balance of effects on 
calcium-dependent ionic conductances may result in positive and negative calcium-voltage 
coupling phenomena, though the former, where an increase in calcium transient amplitude 
prolongs the action potential, is more commonly observed.57 In either case the calcium transient 
will influence the RRepol and, as we have already discussed, a longer action potential will 
demonstrate a greater propensity to shorten, or prolong further, for a fixed change in the RRepol. 
Therefore, any factor that prolongs APD would be predicted to increase the amplitude of 
electrical alternans. This idea is illustrated in Figure 6C, where a beat-to-beat oscillation in the 
calcium transient drives a beat-to-beat oscillation in the RRepol. When APD is prolonged the 
same magnitude oscillation in the RRepol gives rise to APD alternans of greater amplitude. It will 
be immediately obvious that this observation relates back to our previous discussion on APD-
RT and it is already well established that a steeper restitution slope enhances the magnitude of 
electrical alternans.57 A final related factor is that for a given heart rate (i.e. fixed cycle length) 
the DI between subsequent beats will, by definition, be less when the action potential is 
prolonged. As such, hearts will operate on the steeper portion of the APD-RT curve, enhancing 
beat-to-beat alternation of APD (see Figure 6A&B).   
In the setting of spatially discordant alternans, in which regional APD oscillations are out of 
phase, the RRepol-APD curve predicts that having a longer action potential to begin with will 
exacerbate spatial heterogeneities of repolarization, even if APD is uniform across the ventricles 
at baseline. This can be observed Figure 6A, where the difference between long and short 
beats during concordant alternans also reflects spatially gradients of repolarization between two 
regions during discordant alternans. This is important because it is discordant alternans that 
have been shown to be pro-arrhythmogenic. Discordant alternans may increase the likelihood 
that an ectopic stimulus will trigger re-entry, and may also promote spontaneous 
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tachyarrhythmia, by generating a suitable substrate for arrhythmia (i.e. increased spatiotemporal 
dispersion of repolarization).57 APD prolongation will exacerbate this and so may increase 
susceptibility to arrhythmia.  
 
Clinical and technical implications 
Abnormal prolongation of the electrocardiogram QT interval, a measure of the ventricular APD, 
is associated with increased risk of death from malignant ventricular arrhythmia. Inherited 
channelopathies and drug induced long QT syndrome represent the most obvious examples, 
however there is also substantial evidence linking QT prolongation to ventricular 
arrhythmogenesis, and premature mortality, in coronary artery disease,76 chronic heart failure77, 
alcoholic liver disease,78 and in some studies of hypertrophic cardiomyopathy.79 Most strikingly, 
several large-scale population studies indicate that QT prolongation predicts cardiovascular 
mortality in the general population.80-82 In recent decades there has been substantial progress 
towards understanding the cellular mechanisms linking prolonged repolarization to triggered 
electrical activity (early afterdepolarisations) and TdP.83 The principles discussed in this article 
suggest that QT prolongation will also promote dynamic electrical instability, because a 
proportional change in the RRepol results in a greater magnitude change in the APD when 
repolarization is already slowed / prolonged. As such, it is hypothesized that abnormal 
prolongation of the action potential, in any condition, may exacerbate electrophysiological 
phenomena that are associated with malignant ventricular arrhythmia, including, dispersion of 
repolarization, APD-RT kinetics and the magnitude of electrical alternans. Furthermore, the 
RRepol-APD relationship predicts that prolonging the action potential will facilitate instability whislt 
exerting little effect on the cardiac wavelength during tachyarrhythmia.4 These observations may 
be of some importance in understanding of the conflicting results of animal studies using class 
III anti-arrhythmic agents15 and the failure of pure class III drugs in the clinical management of 
ventricular arrhythmia.13, 14  
From a technical standpoint, the fact that a uniform slowing of repolarization will act to magnify 
intrinsic differences in APD (see Figure 4) makes it impossible to attribute a heterogeneous 
change in regional repolarization to non-uniformities in ion channel expression, a fairly common 
assumption in experimental studies. To correctly establish whether the effect of an intervention 
on regional APD can be attributed to regional ion channel expression investigators must also 
consider the initial APD. Assessing the proportional change in the average RRepol, as well as 
APD, may prove to be more informative. There are additional issues of interpretation that arise 
when investigating an intervention that modifies APD. For instance, if we were to take a 
myoycte and measure the APD-RT curve before and after drug treatment we might observe, as 
discussed, a prolongation of APD and a steepening of the restitution relationship. Thus we 
might conclude that the ion channel we have targeted has a role in restitution. In some respects 
this is true, however, it does not tell us that the ion channel in question directly contributes to the 
 12 
adaptation of APD during restitution. As we have already observed, prolongation of APD would 
be expected to influence the APD-RT curve indirectly. Thus, in order to establish the importance 
of a particular ionic conductance it is essential to control for the difference in APD between 
groups. Of course this may be regarded as a somewhat redundant point as the change in APD 
is a direct consequence of the intervention on its target ion channel or pump and so its 
electrophysiological action. 
 
Limitations 
In this article we have discussed the importance of the RRepol-APD relationship as an 
underpinning for common electrophysiological observations, whereby a change in the duration 
of the action potential has predictable consequences that appear to be somewhat independent 
of the mechanism by which APD is modified. It is not, however, our intention to suggest that this 
is the only factor that warrants consideration. Interventions that modify ion channel behavior and 
/ or intracellular ionic composition may effect both the duration of the action potential but also 
the response of the membrane to a given stimulus (e.g. a premature beat). Such factors may 
act in concert or in opposition. Furthermore, ion channel modulating drugs can demonstrate 
either use- or reverse use-dependent block, binding to their target ion channel in the open, 
inactive or resting state. As such, the degree of channel block can vary directly, or inversely, 
with heart rate and may vary from drug to drug. Such drug-channel interactions may oppose or 
augment the RRD attributed to the action potential morphology. The RRepol-APD relationship 
provides a means to predict the effect of any intervention that alters APD, however, on its own it 
may be insufficient to fully explain the electrophysiological changes with drugs or disease.   
It is well established that the cardiac ion channels make a varying contribution at different 
stages of repolarization, owing to their voltage, time and ionic dependencies. As such, the 
approach of measuring repolarization at a single defined point during repolarization could be 
criticized. A change in the RRepol occurring late in repolarization would be expected to have less 
of an impact on the APD then a change that occurs earlier, however this could be addressed by 
using the average RRepol, as in Figure 1D.   
 
Summary 
In this article an argument has been made that the non-linear RRepol-APD relationship explains 
why interventions and disease with disparate modes of action have similar electrophysiological 
consequences. The simple fact that a longer action potential will demonstrate a greater 
propensity to shorten or prolong, for a given change in the RRepol, has important implications.  
With the exception of studies addressing the mechanisms of RRD it appears that this principle 
has been largely overlooked. The RRepol-APD relationship predicts that QT prolongation will 
generate conditions of dynamic electrical instability, exacerbating several electrophysiological 
phenomena associated with ventricular arrhythmia. 
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Figure legends 
 
 
Figure 1. Action potential duration is a non-linear function of the rate of repolarization (net 
ionic current). A&B) Data from isolated ventricular myocytes demonstrating the non-linear relation 
between action potential duration (APD) and net ionic current at 50% repolarization (Im50). APD was 
modified by A) direct current injection (outward – diamonds, inward – triangles) and B) by 
pharmacological interventions. Reproduced with permissions from Bányász et al.4 and Bárándi et al.5, 
respectively. C) Example monophasic action potential recordings, along with their first derivatives, 
showing the relationship between monophasic APD (MAPD) and the rate of repolarization in an 
isolated rabbit heart. Arrows denote 50% repolarization (unpublished observations). D) Plotting 
monophasic action potential duration (MAPD90) as a function of the average rate of repolarization 
reveals a non-linear relationship comparable to that observed in isolated myocytes. MAP recordings 
were made over range of heart rates in rabbit hearts in control conditions and in the presence of 
E4031 (50nM), a selective inhibitor of the rapid delayed rectifying potassium current. For analysis the 
amplitude of the plateau was normalized to 1. Average repolarization was assessed as the mean of 
the first derivative of the action potential waveform from the peak of the plateau (i.e. after the notch) 
to 90% repolarization (n=5, unpublished observations).  
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Figure 2. An intrinsic geometrical relationship between the rate of repolarization and 
action potential duration. Representative diagram. RRepol=Rate of repolarization, APD=action 
potential duration. 
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Figure 3. Reverse rate-dependence is an intrinsic property of the cardiac membrane. Data 
from isolated canine ventricular myocytes demonstrating the reverse rate-dependent modulation 
of action potential duration (APD) with A) drugs that prolong and shorten repolarization and B) 
direct injection of inward (+) and outward (-) current during microelectrode recordings. C) 
Reverse rate-dependent prolongation of APD as a result of inhibition of the inwardly rectifying 
potassium current (IK1) is abolished by the application of an opposing outward current, indicating 
this is an intrinsic property of the cardiac membrane and not explained by the mode of action of 
BaCl2. Reproduced with permissions from Bányász et al.4 
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Figure 4. Rate dependence of dispersion of repolarization. A) Modeling the effect of heart 
rate on regional action potential duration (APD). Slowing of heart rate is represented as a 
uniform reduction (0.1 mV/ms) in the rate of repolarization (RRepol) in two ventricular regions with 
different APD (R1 and R2). The initial difference in APD (dispersion) between the two regions is 
predicted to increase when heart rate is reduced from fast (circle) to slow (square) rates. B) The 
increase in dispersion with bradycardia is predicted to be dependent upon the starting 
conditions, whereby the effects of slowing rate are magnified when the initial difference in APD 
between the two regions (R1 and R2) is greater. C) Monophasic action potential recordings from 
an isolated rabbit heart demonstrating the increase in dispersion of repolarization (dotted lines) 
associated with vagally mediated bradycardia. Note the greater prolongation of action potential 
duration in apical regions, which are longer to begin with. Treatment with E4031, a selective 
inhibitor of the rapid delayed rectifying potassium current, increases baseline dispersion and 
potentiates the effects of bradycardia. D) Data from the same study demonstrating a correlation 
between initial monophasic action potential duration (MAPD90) and the magnitude of change in 
MAPD90 during bradycardia (n=8 hearts). Data reproduced with permissions from Winter et al.
35 
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Figure 5. Action potential duration restitution kinetics. A) Predicted effect of an increase in 
action potential duration (APD) on the APD restitution (APD-RT) from the rate of repolarization 
(RRepol)-APD relationship. Curves were generated by plotting step increases in the RRepol (0.025 
mV/ms per step), from two different starting values for APD (denoted by the rightmost arrows 
(1)), for a total of 10 steps (final values denoted by the leftmost arrows (10)). This models the 
shortening of APD during restitution and predicts that a longer action potential will be associated 
with a greater magnitude of APD shortening over a given range of DIs, a steeper APD-RT slope 
and that curves will converge towards the same point. This prediction is supported by 
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experimental data assessing differences in APD-RT with B) different pacing rates (guinea-pig),46 
C) between endocardial and epicardial myoyctes (dog),84 D) with the electromechanical 
uncoupling agents 2,3-Butanedione 2-monoxime (rabbit),55 E) in pacing induced heart failure 
(dog),42 and with drugs that F) augment (pig)50 or G) block outward potassium currents (dog).47 
Data re-plotted for clarity, with permissions. ARI=activation recovery interval.  
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Figure 6. Electrical alternans. A) Experimental data from anaesthetized guinea pigs. 
Significant electrical alternans are observed during rapid pacing (150ms cycle length (CL)) when 
APD is prolonged by E4031 treatment (23 nmol/L), but not in control conditions. Data 
reproduced with permissions from Fossa et al.65 B) Data from isolated guinea pig hearts 
demonstrating the effect of a sudden decrease in cycle length (CL) on the magnitude of 
electrical alternans in electrocardiogram (ECG) and monophasic action potential (MAP) 
recordings. Treatment with nicorandil shortens the action potential and reduces the amplitude of 
alternans associated with disopyramide treatment. Data reproduced with permission from 
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Fujimoto et al.67 C) Predicted effect of beat-to-beat oscillations in the rate of repolarization 
(RRepol) on action potential duration (APD), reflecting cycling of intracellular calcium transient 
amplitude at fast heart rates. Data are an example of positive calcium to voltage coupling. When 
APD is prolonged the same magnitude change in the RRepol (0.3 mV/ms) is associated with a 
greater change in APD, as can be seen from the difference between beats 1 (B1) & 2 (B2). Amp 
= alternan amplitude. In the setting of spatially discordant alternans dispersion of repolarization 
(DOR), between two out of phase regions (R1 and R2), is predicted to be greater when the 
action potential is prolonged. 
 
